Low-Density Lipoprotein Nanoparticles as Magnetic Resonance Imaging Contrast Agents
Open Access
- 1 June 2006
- journal article
- Published by Elsevier BV in Neoplasia
- Vol. 8 (6), 488-498
- https://doi.org/10.1593/neo.05835
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- High payload delivery of optical imaging and photodynamic therapy agents to tumors using phthalocyanine-reconstituted low-density lipoprotein nanoparticlesJournal of Biomedical Optics, 2005
- Improved molecular imaging contrast agent for detection of human thrombusMagnetic Resonance in Medicine, 2003
- Molecular imaging in living subjects: seeing fundamental biological processes in a new lightGenes & Development, 2003
- Magnetic resonance contrast enhancement of neovasculature with ?v?3-targeted nanoparticlesMagnetic Resonance in Medicine, 2000
- Plasma stability and cytotoxicity of lipophilic daunorubicin derivatives incorporated into low density lipoproteinsEuropean Journal of Medicinal Chemistry, 2000
- Apolipoprotein B-100 Conformation and Particle Surface Charge in Human LDL Subspecies: Implication for LDL Receptor InteractionBiochemistry, 1998
- Internalization of indium-labeled LDL through a lipid chelating anchor in human pancreatic-cancer cells as a potential radiopharmaceutical for tumor localizationInternational Journal of Cancer, 1997
- Hepatic Circulation and ToxicologyDrug Metabolism Reviews, 1997
- Efficacy evaluation of gadoteridol for MR angiography of intracranial vascular lesionsJournal of Magnetic Resonance Imaging, 1994
- Biodistribution study of 99mTc‐labeled LDL in B16‐melanoma‐bearing mice. Visualization of a preferential uptake by the tumorInternational Journal of Cancer, 1993